Biopolym. Cell. 2000; 16(4):260-269.
http://dx.doi.org/10.7124/bc.00056F
Огляди
Тейхоєві кислоти бактерій та їхні біологічні властивості
1Позур В. К., 1Сенчило Н. В., 1Пасічник І. П.
  1. Київський національний університет імені Тараса Шевченка
    вул. Володимирська 64, Київ, Україна, 01033

Abstract

Огляд присвячено вивченню тейхоевих кислот бактерій та їхніх біологічних властивостей. Значну увагу приділено розкриттю структури та фізико-хімічних особливостей тейхоевих кислот бактерій, їхній ролі у функціонуванні бактеріальної клітини та впливові на організм ссавців, зокрема, на імунну систему (індукція реакцій клітинного імунітету, синтез антитіл, продуку­вання цитокінів, активація системи комплемента).
Повний текст: (PDF, українською)

References

[1] Deriabin PN, Karal'nik BV, Vaneeva NP, Slastikhin BA, Tereshchenko LI. [Serological diagnosis of suppurative-septic diseases of staphylococcal etiology]. Zh Mikrobiol Epidemiol Immunobiol. 1987;(7):38-41. Russian.
[2] Naumova IB, Shashkov AS. Anionic polymers in cell walls of gram-positive bacteria. Biochemistry (Mosc). 1997;62(8):809-40.
[3] Evtushenko LI, Lysak LV, Dobrovolskaya TG, Chernyakovskaya EF, Zgurskaya EI, Ilchenko VYa, Adanin VM, Kalakutskii LV. Actinomycetes containing diaminobutyric acid in the cell wall isolated from soil. Mikrobiologiia. 1991;60(5):920-1.
[4] Fischer W. One-step purification of bacterial lipid macroamphiphiles by hydrophobic interaction chromatography. Anal Biochem. 1991;194(2):353-8.
[5] Greenberg JW, Fischer W, Joiner KA. Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect Immun. 1996;64(8):3318-25.
[6] Bhakdi S, Mannhardt U, Muhly M, Hugo F, Ronneberger H, Hungerer KD. Human hyperimmune globulin protects against the cytotoxic action of staphylococcal alpha-toxin in vitro and in vivo. Infect Immun. 1989;57(10):3214-20.
[7] Deriabin PN, Karal'nik BV. Biological properties and use of teichoic acids from microorganisms. Zh Mikrobiol Epidemiol Immunobiol. 1983;(1):15-21.
[8] Reeder WJ, Ekstedt RD. Unique teichoic acid isolated from the cell walls of a strain of Staphylococcus aureus. Infect Immun. 1973;7(4):586-8.
[9] Karakawa WW, Kane JA. Immunochemical analysis of a galactosamine-rich teichoic acid of Staphylococcus aureus, phage type 187. J Immunol. 1971;106(4):900-6.
[10] Jonsen GS, Oeding P. Infections of human mannose-binding protein with lipoteichoic acids. Acta Path Microbiol Scand Sect. B. 1975; 83:235-9.
[11] Ayyagari A, Pal N. Antiribitol-teichoic acid antibody (ARTA) in diagnosis of deep seated Staphylococcus aureus infections. Indian J Pathol Microbiol. 1991;34(3):176-80.
[12] Fischer W. Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus. Med Microbiol Immunol. 1994;183(2):61-76.
[13] Damen JJ, Exterkate RA, ten Cate JM. Lipoteichoic acid inhibits remineralization of artificial subsurface lesions and surface-softened enamel. J Dent Res. 1995;74(10):1689-94.
[14] Vershigora AE, Pozur VK. Immunobiological properties of teichoic acids. Zh Mikrobiol Epidemiol Immunobiol. 1982;(8):31-8.
[15] Pooley HM, Karamata D, Ghuysen JM, Hackenbeck R. Bacterial cell wall. New Comprehensive Biochem. 1994. 27: 187-98.
[16] Archibald AR, Randall LL. Virus receptor (receptors and recognition). Chapman and Hall. 1980. 7: 7-26.
[17] Leopold K, Fischer W. Separation of the poly(glycerophosphate) lipoteichoic acids of Enterococcus faecalis Kiel 27738, Enterococcus hirae ATCC 9790 and Leuconostoc mesenteroides DSM 20343 into molecular species by affinity chromatography on concanavalin A. Eur J Biochem. 1991;196(2):475-82.
[18] Gnilozub VA, Streshinskaya GM, Evtushenko LI, Shashkov AS, Naumova IB. Lipoteichoic acids of Agromyces species. Mikrobiologiia. 1994;63(3):495-502.
[19] Renzi PM, Lee C-H. A comparative study of biological activities of lipoteichoic acid and lipopolysaccharide. Innate Immunity. 1995;2(6):431-41.
[20] Ravindranath RM, Mondino BJ, Adamu SA, Pitchekian-Halabi H, Hasan SA, Glasgow BJ. Immunopathologic features of Staphylococcus aureus endophthalmitis in the rat. Invest Ophthalmol Vis Sci. 1995;36(12):2482-91.
[21] Aly R, Shinefield HR, Litz C, Maibach HI. Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells. J Infect Dis. 1980;141(4):463-5.
[22] Bolton RW. Cyclic antibody formation to polyglycerophosphate in normal and infected rats. Arch Oral Biol. 1980; 25:111-4.
[23] Vercellotti GM, Lussenhop D, Peterson PK, Furcht LT, McCarthy JB, Jacob HS, Moldow CF. Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med. 1984;103(1):34-43.
[24] Matsuura T, Miyake Y, Nakashima S, Komatsuzawa H, Akagawa Y, Suginaka H. Isolation and characterization of teichoic acid-lake substance as an adhesin of Staphylococcus aureus to HeLa cells. Microbiol Immunol. 1996;40(4):247-54.
[25] Verbrugh HA, Peterson PK, Smith DE, Nguyen BY, Hoidal JR, Wilkinson BJ, Verhoef J, Furcht LT. Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun. 1981;33(3):811-9.
[26] Ward TT. Comparison of in vitro adherence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus to human nasal epithelial cells. J Infect Dis. 1992;166(2):400-4.
[27] Coyette J, Ghuysen JM. Structure of the cell wall of Staphylococcus aureus, strain Copenhagen. IX. Teichoic acid and phage adsorption. Biochemistry. 1968;7(6):2385-9.
[28] Carratelli CR, Nuzzo I, Bentivoglio C, Galdiero M. CD11a/CD18 and CD11b/18 modulation by lipoteichoic acid, N-acetyl-muramyl-alpha-alanyl-D-isoglutamine, muramic acid and protein A from Staphylococcus aureus. FEMS Immunol Med Microbiol. 1996;16(3-4):309-15.
[29] Aly R, Levit S. Adherence of Staphylococcus aureus to squamous epithelium: role of fibronectin and teichoic acid. Rev Infect Dis. 1987;9 Suppl 4:S341-50.
[30] Myanski DN, Scherbakov KI, Pravorotov KN. Disinhibition of the mononuclear phagocyte system microbial stimulants. Patfiziologiya i eksperim. terapiya. 1983;(4):52-5.
[31] Chapekar MS, Zaremba TG, Kuester RK, Hitchins VM. Synergistic induction of tumor necrosis factor alpha by bacterial lipopolysaccharide and lipoteichoic acid in combination with polytetrafluoroethylene particles in a murine macrophage cell line RAW 264.7. J Biomed Mater Res. 1996;31(2):251-6.
[32] Chorpennin FM, Cooper HR. Spontaneous adsorption of teichoic acids to erytrocytes. Infect Immun. 1975; 12: 586-91.
[33] J?rgensen J, Bach-Mortensen N, Koch C, Fomsgaard A, Baek L, Jarl?v JO, Espersen F, Jensen CB, Skov PS, Norn S. Bacteria and endotoxin induce release of basophil histamine in patients with atopic dermatitis. In vitro experiments with S. aureus, teichoic acid, E. coli and E. coli LPS. Allergy. 1987;42(5):395-7.
[34] Norn S, Jarl?v JO, Jensen CB, Clementsen P, Dahl BT, Espersen F, Stahl Skov P. Bacteria and their products peptidoglycan and teichoic acid potentiate antigen-induced histamine release in allergic patients. Agents Actions. 1987;20(3-4):174-7.
[35] Ofek I, Whitaker JN, Campbell GL, Beachey EH. Interaction of group A streptococcal lipoteichoic acid with bovine myelin basic protein. J Infect Dis. 1979;139(1):93-6.
[36] Kengatharan KM, De Kimpe S, Robson C, Foster SJ, Thiemermann C. Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med. 1998;188(2):305-15.
[37] Kengatharan M, De Kimpe SJ, Thiemermann C. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br J Pharmacol. 1996;117(6):1163-70.
[38] Kengatharan KM, De Kimpe SJ, Thiemermann C. Role of nitric oxide in the circulatory failure and organ injury in a rodent model of gram-positive shock. Br J Pharmacol. 1996;119(7):1411-21.
[39] Traub WH, Bauer D, Leonhard B. Immunobiology of methicillin-resistant Staphylococcus aureus: immune response of rabbits and patients to systemic infection. Chemotherapy. 1996;42(2):118-32.
[40] Lebedev KA, Shibanova EM, Rumiantseva MG, Turchaninova GD, Dolgikh EI. Heterogeneity of agglutinability and antibiotic sensitivity of a population of Staphylococcus aureus isolated from tonsillar lacunae of patients with angina and chronic tonsillitis. Zh Mikrobiol Epidemiol Immunobiol. 1981;(2):41-5.
[41] Engstrom RE Jr, Mondino BJ, Glasgow BJ, Pitchekian-Halabi H, Adamu SA. Immune response to Staphylococcus aureus endophthalmitis in a rabbit model. Invest Ophthalmol Vis Sci. 1991;32(5):1523-33.
[42] Neuber K, K?nig W. Effects of Staphylococcus aureus cell wall products (teichoic acid, peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgG) synthesis and CD23 expression in patients with atopic dermatitis. Immunology. 1992;75(1):23-8.
[43] Tsuneyoshi I, Kanmura Y, Yoshimura N. Lipoteichoic acid from Staphylococcus aureus depresses contractile function of human arteries in vitro due to the induction of nitric oxide synthase. Anesth Analg. 1996;82(5):948-53.
[44] Hattor Y, Kasai K, Akimoto K, Thiemermann C. Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway. Biochem Biophys Res Commun. 1997;233(2):375-9.
[45] Auguet M, Lonchampt MO, Delaflotte S, Goulin-Schulz J, Chabrier PE, Braquet P. Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells. FEBS Lett. 1992;297(1-2):183-5.
[46] Leung DY, Ambrosino DM, Arbeit RD, Newton JL, Geha RS. Impaired antibody responses in the hyperimmunoglobulin E syndrome. J Allergy Clin Immunol. 1988;81(6):1082-7.
[47] Martin V, Kleschyov AL, Klein JP, Beretz A. Induction of nitric oxide production by polyosides from the cell walls of Streptococcus mutans OMZ 175, a gram-positive bacterium, in the rat aorta. Infect Immun. 1997;65(6):2074-9.
[48] Chugh TD, Burns GJ, Shuhaiber HJ, Bahr GM. Adherence of Staphylococcus epidermidis to fibrin-platelet clots in vitro mediated by lipoteichoic acid. Infect Immun. 1990;58(2):315-9.
[49] Proskurnyakov SYa, Konoplyannikov AG, Ivannikov AI, Skvortsov VG. Biology of nitric oxide. Usp Sovrem Biol. 1999; 119(4):380-95.
[50] Standiford TJ, Arenberg DA, Danforth JM, Kunkel SL, VanOtteren GM, Strieter RM. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immun. 1994;62(1):119-25.
[51] Hattori Y, Kasai K, Nakanishi N, Gross SS, Thiemermann C. Induction of nitric oxide and tetrahydrobiopterin synthesis by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells. J Vasc Res. 1998;35(2):104-8.
[52] Bhakdi S, Muhly M. Isolation and partial characterization of staphylococcal decomplementation antigen. Infect Immun. 1985;47(1):47-51.
[53] Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun. 1991;59(12):4614-20.
[54] Carratelli CR, Nuzzo I, Bentivoglio C, Galdiero M. CD11a/CD18 and CD11b/18 modulation by lipoteichoic acid, N-acetyl-muramyl-alpha-alanyl-D-isoglutamine, muramic acid and protein A from Staphylococcus aureus. FEMS Immunol Med Microbiol. 1996;16(3-4):309-15.
[55] Rudnicka W, Sadowska B, Ljungh A, R?zalska B. Specific immune response to staphylococcal antigens during long-lasting biomaterial implantation. FEMS Immunol Med Microbiol. 1997;19(1):7-14.
[56] Targowski SP, Berman DT. Cell-mediated immune reactions in vitro to cell walls and peptidoglycan from Staphylococcus aureus. Z Immunitatsforsch Exp Klin Immunol. 1975;149(2-4):295-301.
[57] Bobrovnik SA, Bekhalo VA. Specific binding of corpuscular staphylococcal antigen by the lymphocytes of CBA strain mice. Fiziol Zh. 1982;28(5):623-6.
[58] Ryding U, Renneberg J, Rollof J, Christensson B. Antibody response to Staphylococcus aureus whole cell, lipase and staphylolysin in patients with S. aureus infections. FEMS Microbiol Immunol. 1992;4(2):105-10.
[59] Vaneeva NP, Mezhevitinov VB, Bagirova NS. Detection of antibodies to preparations of Staphylococcus aureus peptidoglycan, teichoic acids and polysaccharide in patients' sera. Zh Mikrobiol Epidemiol Immunobiol. 1987;(8):85-8.
[60] Wise KA, Tosolini FA. Detection of teichoic acid antibodies in Staphylococcus aureus infections. Pathology. 1992;24(2):102-8.
[61] Iastrebova NE, Vaneeva NP, Mezhevitinov VB, Stepanova OV. [Comparative immunochemical characteristics of extracellular polysaccharide-containing preparations and teichoic acids of Staphylococcus aureus]. Zh Mikrobiol Epidemiol Immunobiol. 1986;(8):14-8.
[62] Beining PR, Flannery GM, Prescott B, Baker PJ. Influence of carrier-specific, thymus-derived cells on the immunologlobulin M antibody response to staphylococcal lipoteichoic acid. Infect Immun. 1980;29(1):132-9.
[63] Wergeland HI, Haaheim LR, Nat?s OB, Wesenberg F, Oeding P. Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections. J Clin Microbiol. 1989;27(6):1286-91.
[64] Giese MJ, Adamu SA, Pitchekian-Halabi H, Ravindranath RM, Mondino BJ. The effect of Staphylococcus aureus phage lysate vaccine on a rabbit model of staphylococcal blepharitis, phlyctenulosis, and catarrhal infiltrates. Am J Ophthalmol. 1996;122(2):245-54.
[65] Oeding R, Wergeland H. Staphylococci and Staphylococcal infections. Ed. J. Jeijaszewiez. Basel, 1983: 77-82.
[66] Greenberg DP, Bayer AS, Turner D, Ward JI. Antibody responses to protein A in patients with Staphylococcus aureus bacteremia and endocarditis. J Clin Microbiol. 1990;28(3):458-62.
[67] Yokoyama Y, Harabuchi Y, Kodama H, Murakata H, Kataura A. Systemic immune response to Streptococcal and Staphylococcal lipoteichoic acids in children with recurrent tonsillitis. Acta Otolaryngol Suppl. 1996;523:108-11.